Personalized Drug Testing for Liver Cancer After Surgery
Treatments studied
Part of Cancer clinical trials.
This trial tests whether a personalized treatment plan based on a lab-grown 3D model of your tumor (called an organoid) can help prevent your liver cancer from coming back after surgery. The goal is to find the most effective drugs for your specific cancer.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 70 years old.
- You were diagnosed with liver cancer (specifically hepatocellular carcinoma) and had surgery to remove it. After surgery, your tumor had at least one high-risk feature: larger than 5 cm, more than 3 tumors, blood vessel invasion, or a higher-grade (poorly differentiated) cancer.
- Your liver function is good enough (Child-Pugh class A or B with a score of 7).
- You have not had radiation therapy in the last 12 weeks, and you are not pregnant or breastfeeding.
- Your blood counts, kidney and liver function, and blood clotting are within safe ranges (your doctor will check these).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial is for people with early-stage liver cancer who are scheduled for surgery. It uses a simple blood test to look for tiny bits of tumor DNA after treatment, which may help predict if the cancer will come back.
This trial tests new treatment plans for people with advanced liver cancer that has worsened after initial therapy. The goal is to find more effective, personalized options based on how your cancer responds.
This trial tests a personalized mRNA vaccine made from your tumor's unique genetic markers. It is for people with advanced liver cancer who have not yet received any treatment.
This study looks at genetic markers in the blood of people with liver cancer who are having surgery, either right away or after some treatment first. It aims to find out why some patients do better, which could help personalize care.
This trial tests whether growing your tumor cells in a lab (organoids) can help pick the best drug for your advanced liver cancer. It aims to make treatment more personalized and effective.
This trial uses advanced testing (genetic sequencing and lab-grown tumor models) to find the best treatment for people with advanced solid tumors that haven't responded to at least one standard treatment. The goal is to personalize therapy based on your tumor's unique features.
Hear when a new Hepatocellular Carcinoma Resectable trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.